formula with the use of an HP 5659 ventricular angiography workstation (Hewlett Packard, Mountain View, CA). Depending on the result of reperfusion therapy, the 22 patients were divided into two groups: successful reperfusion (group A: n=13) and no reperfusion (group B: n=9). Successful reperfusion was defined as an improvement of coronary flow to TIMI grade 2 or 3.12) In group A, all infarct-related coronary arteries were confirmed to be open in the chronic phase. In group B, 6 patients had unsuccessful recanalization and 3 patients did not receive recanalization therapy. Coronary angiography in the chronic stage showed all infarct-related arteries were occluded in group B. Serum myosin light chain was measured in eight other patients with acute myocardial infarction who had no prior myocardial infarction (group C). Blood sampling: Blood samples were obtained on admission and every 3 hours during the first 24 hours, every 6 hours during the next 48 hours, then every 12 hours until 7 days after admission. Serum troponin T and conventional cardiac enzymes (creatine phosphokinase, glutamic oxaloacetic transaminase and lactate dehydrogenase) were also measured in the same blood samples. Serum cardiac troponin T, myosin light chain and creatine phosphokinase assay: Serum troponin T was measured by enzyme-linked immunosorbent assay as previously reported.9) This assay is manufactured as a test kit consisting of 7 components: antibody-coated test tubes, monoclonal antibody-enzyme complex, incubation buffer, troponin T standard, control serum, substrate buffer, and the diammonium salt of 2.2' azino-bis (3-ethylbenzothiazoline-6-sulphonic acid). For serum troponin T measurements, the antibody-enzyme complex, troponin T standards, and the diammonium salt of 2.2'-azino-bis substrate are dissolved in the buffer solution provided in the test kit and mixed thoroughly with a vortex mixer. Troponin T standards or unknown patient serum (200ml) is added manually to the test tubes, and 1ml of antibody-enzyme complex (45IU) and all the remaining solutions are added by a batch enzyme-linked immunosorbent assay analyzer (Enzyme Test ES 22; Boehringer Mannheim, Germany). Solidphase antibody, troponin T-coating solutions, and antibody-enzyme complex are incubated at room temperature for 60 minutes. The tubes are then emptied by suction and washed twice with tap water. To each test tube 1ml substrate solution is added, and the substrate conversion is measured as color formation after 30 minutes of incubation at room temperature. The normal range in this assay is reported to be less than 0.5pg/l.
Myosin light chain is measured with the radio immunoassay developed by Isobe et al,13) and creatine phosphokinase is measured spectrophotometrically at 340nm as described by Rosalki.14) Detection of reperfusion from serial changes of troponin T: Because coronary reperfusion would influence the rate of appearance in the serum, the rate of A significant correlation was also observed between TnT-24, 36, 48, 60 and the left ventricular ejection fraction in the chronic stage (Figure 4) . Although there was no statistically significant difference in correlation coefficients among these values, TnT-60 appeared to have the highest correlation coefficient. DISCUSSION We have shown that the peak value of serum troponin T has a good correlation with left ventricular ejection fraction in the chronic stage of acute myocardial infarction and that the rate of increase in serum troponin T may predict coronary reperfusion. Detection of coronary reperfusion:
In the modern era of reperfusion therapy for acute myocardial infarction, the estimation of infarct size from conventional cardiac enzyme levels seems inappropriate. The conventional markers such as early increase of creatine phosphokinase, early disappearance of chest pain and early decrease of ST elevation in the 12-lead electrocardiograph have been found to have only low reliability.15) Serum myoglobin has been reported to be able to detect coronary reperfusion quickly because of its rapid kinetics. However, it has a low specificity for cardiac injury because it is also present in skeletal muscle, and its rapid disappearance from serum may lead to misjudgment of recanalization. Cardiac troponin T is a component of contractile proteins and 6% of all troponin T exists in the cytosol in a soluble unbound form.10) Serum troponin T has been reported to start rising 3.5 hours after the onset of acute myocardial infarction (slightly earlier than serum creatine phosphokinase), persists for more than 10 days and has a high diagnostic potential because of its cardiospecificity.16) As shown in this study, the release of troponin T in acute myocardial infarction is typically biphasic, and it has been reported9) that the first peak of serum troponin T is composed mainly of soluble unbound troponin T and the late peak reflects continuing myocardial damage.10) Recently, Abe et al reported that an increase in serum troponin T 60 minutes after reperfusion therapy can be applied to detect successful reperfusion in patients with acute myocardial infarction.11) In this study, the slope of the logarithm of the serum troponin T-time curve in the early phase of reperfusion after acute myocardial infarction was higher than that when there was no reperfusion. Although the index used in this study is different from theirs, our results support their conclusion. When successful reperfusion was achieved, the first peak of serum troponin T may be composed mainly of washout of unbound troponin T from the cytosol due to reperfusion of the occluded coronary artery. Thus, release of unbound troponin T in the cytosol must be sensitive to reperfusion, and measurement of the rate of this release might detect coronary reperfusion. However, the specific-ity of the detection of reperfusion by the slope of the logarithm of the serum troponin T-time curve was 73%, which seems relatively low. This may be due to the small number of samplings. If sampling is done more often during the early phase of acute myocardial infarction and the time needed to measure serum troponin T can be shortened, a better non-invasive judgment of coronary reperfusion may be possible. Evaluation of left ventricular function: Although peak creatine phosphokinase has been in general use for the evaluation of infarct size,7) it does not necessarily correlate with the left ventricular function at the chronic stage when successful reperfusion is achieved,6,17) probably because of the false increase in peak creatine phosphokinase due to the washout phenomenon. In this study, the peak creative phosphokinase level was examined in 11 patients with first Q wave acute myocardial infarction, and there was no significant correlation between the left ventricular ejection fraction and peak creatine phosphokinase, because this group contained both reperfused and non-reperfused acute myocardial infarction patients. Thus, without information about the reperfusion situation, one cannot predict left ventricular function in the chronic stage from the peak creatine phosphokinase value. In contrast, correlation coefficients between the troponin T level and the left ventricular ejection fraction were excellent in the same patient group. Isobe et al reported that the serum level of myosin light chain reflected changes in left ventricular function after acute myocardial infarction regardless of the presence or absence of coronary reperfusion.13) In this study, we have shown that the predictive ability of troponin T is similar to or better than that of serum myosin light chain. Serum contractile proteins such as troponin T and myosin light chain appear to reflect myocardial necrosis better than do conventional cardiac enzymes. However, myosin light chain is more influenced by renal dysfunction and has lower cardiospecificity (12% cross-reactivity with skeletal muscle) than troponin T (1-2%).9) Therefore, troponin T may have an advantage over myosin light chain in the prediction of left ventricular function in the chronic stage. Moreover, the troponin T level 60 hours after the onset of acute myocardial infarction showed a correlation coefficient similar to the late peak of troponin T, indicating that it may be possible to predict infarct size by measuring serum troponin T at a single sampling point about 60 hours after the onset of acute myocardial infarction. This would be economically useful. Limitations of this study: The major limitation of judging the presence of coronary reperfusion from serum troponin T is that the assay takes about 90 min, which makes it too late to decide the next strategy after intravenous thrombolysis has failed. Moreover, troponin T in the first sample of serum was elevated in only 11 of the 22 patients with acute myocardial infarction in this series. Therefore, we hope to improve the method of serum troponin T assay and shorten the time required to obtain results.
